Successful management of intralenticular Ozurdex injection causing cataract and intractable glaucoma

A 50-year-old female presented with profound vision loss and was previously advised injection Ozurdex in the left eye. In the left eye, the anterior chamber was quiet, intraocular pressure (IOP) was 58 mmHg and cataractous changes were noted with Ozurdex implant inside the lens substance. The left eye had glaucomatous cupping (0.9:1 CDR), bipolar rim thinning, inferior notch and healed choroiditis. The patient underwent phacoemulsification, trabeculectomy and mitomycin-C in the left eye. Visual acuity improved and IOP was under control. Although Ozurdex is effective, there are reports of complications related to the drug and implantation procedure. This case highlights an uncommon complication of an uncontrolled, persistent steroid response leading to glaucomatous optic atrophy and profound vision loss due to an accidental intralenticular implantation of Ozurdex. Our case reinforces the need for caution about the decision regarding the judicious use of intravitreal steroids and employment of appropriate technique.

[1]  M. Şekeroğlu,et al.  Intralenticular Sustained-Release Dexamethasone Implant: Is It Still Effective on Macular Edema? , 2016, Case Reports in Ophthalmology.

[2]  F. Bandello,et al.  Accidental injection of dexamethasone intravitreal implant in the crystalline lens , 2014, Acta ophthalmologica.

[3]  J. García-Martínez,et al.  Accidental Injections of Dexamethasone Intravitreal Implant (Ozurdex®) into the Crystalline Lens , 2014, European journal of ophthalmology.

[4]  C. Roșca,et al.  Repositioning and follow-up of intralenticular dexamethasone implant. , 2013, Journal of cataract and refractive surgery.

[5]  R. Roy,et al.  Split Ozurdex implant: a caution. , 2013, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[6]  A. Agarwal,et al.  Phacoemulsification and intraocular lens implantation after inadvertent intracapsular injection of intravitreal dexamethasone implant , 2012, BMJ Case Reports.

[7]  L. Wheeler,et al.  Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant. , 2011, Investigative ophthalmology & visual science.

[8]  S. Whitcup,et al.  Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. , 2010, Investigative ophthalmology & visual science.

[9]  Jane S. Myung,et al.  Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant , 2010, Clinical ophthalmology.

[10]  George A. Williams,et al.  Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. , 2010, Archives of ophthalmology.